Defense Health Agency Contracting Activity - DHACA
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing September 30, 2026.
Sep 30, 2026
(61d left)Overview
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed…